Open AccessAntibiotics Susceptibility Pattern of Clinical and Environmental Escherichia coli Isolates from Babylon Hospitals
Author(s) -
Zainab Hasan Abed,
Eman M. Jarallah
Publication year - 2019
Publication title -
journal of physics. conference series
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 85
eISSN - 1742-6596
pISSN - 1742-6588
DOI - 10.1088/1742-6596/1294/6/062105
Subject(s) - colistin , ciprofloxacin , microbiology and biotechnology , amikacin , imipenem , ceftazidime , carbenicillin , meropenem , piperacillin , medicine , ampicillin , antibiotics , biology , antibiotic resistance , bacteria , pseudomonas aeruginosa , genetics
A total of (400) clinical and environmental samples were collected during the period from Sep/2018 to Jan/2019 from different hospitals in Hilla city. The isolates were identified and based on microscopic features and standard biochemical tests. The results showed there were (150) isolates of E.coli from clinical and the environmental samples. The clinical isolates (67 isolates) were collected from patients suffering from different infections such as UTI (30 isolates), gastroenteritis (diarrhea) (22 isolates), and wound infections (15 isolates). Also, the environmental isolates (83) were collected from the different site of hospitals environment include surgery room, hospital floors, the hospital cafeteria, the corridors of the hospital, and from workers dress and stool. All 150 E.coli isolates were primarily screened for colistin resistance, The following antibiotics were used for susceptibility testing to the resistance isolates for colistin (17 isolates): Aminoglycosides (Amikacin, Gentamicin, kanamycin ), Sulfonamide (Trimethoprim), Nitrofurans (Nitrofurantoin), Fluoroquinolons (Ciprofloxacin, Norfloxacin), Cefeme (Cephalothin, Ceftriaxone, Ceftazidime), Macrolides (Erythromycin), carbapenems (Imipenem, meropenem), beta-Lactams (Amoxicillin, Carbenicillin ), Tetracyclin, Chloramphenicol. our result show that E. coli the most causative agent of UTI infection especially in women. there is a high resistance to cefems and beta- lactam antibiotic (100%) among these isolates which play as a cell wall inhibitors. And moderate resistance to ciprofloxacin (52.9%), Chloramphenicol and Norfloxacin (29.14%), and weak resistance to Gentamycin.